Vitrafy Life Sciences (ASX:VFY) Total Stockholders Equity: A$41.11 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:VFY Vitrafy Life Sciences Ltd ASX:VFY
4 GF Score
Price A$3.87
! 2 Warning Signs
View Full Analysis

What is Vitrafy Life Sciences Total Stockholders Equity?

Vitrafy Life Sciences ASX:VFY -1.53% 4 Total Stockholders Equity is A$41.11 Mil as of Jun. 2026. GuruFocus rates ASX:VFY with a GF Score™ of 4/100. The stock has 2 warning signs investors should review.

Vitrafy Life Sciences's Total Stockholders Equity for the quarter that ended in Jun. 2026 was A$41.11 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vitrafy Life Sciences's Book Value per Share for the quarter that ended in Jun. 2026 was A$0.55. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vitrafy Life Sciences's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.01.

Vitrafy Life Sciences  (ASX:VFY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vitrafy Life Sciences's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(41.107-0)/75.388
=0.55

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vitrafy Life Sciences's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.059 + 0.243) / 41.107
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrafy Life Sciences Total Stockholders Equity Related Terms

Vitrafy Life Sciences Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Vitrafy Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrafy Life Sciences Total Stockholders Equity Chart

Vitrafy Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Total Stockholders Equity
0.00 0.00 39.99 28.77 41.11

Vitrafy Life Sciences Semi-Annual Data
Jun22 Jun23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial 39.99 34.71 28.77 21.65 41.11
ASX:VFY
4GF Score
Vitrafy Life Sciences Ltd ASX:VFY
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of A$41.11 Mil mean?
Vitrafy Life Sciences (ASX:VFY) has a Total Stockholders Equity of A$41.11 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Vitrafy Life Sciences and its competitors.
Is Vitrafy Life Sciences' Total Stockholders Equity too high?
Vitrafy Life Sciences' current Total Stockholders Equity is A$41.11 Mil. Overall, Vitrafy Life Sciences has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Vitrafy Life Sciences' Total Stockholders Equity compare to MSFT and PLTR?
Vitrafy Life Sciences' Total Stockholders Equity of A$41.11 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Software company?
A good Total Stockholders Equity depends on the Software industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Vitrafy Life Sciences and its competitors. Vitrafy Life Sciences's current Total Stockholders Equity is A$41.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrafy Life Sciences stock overvalued right now?
Vitrafy Life Sciences (ASX:VFY) has a current Total Stockholders Equity of A$41.11 Mil. The current Total Stockholders Equity is A$41.11 Mil. Vitrafy Life Sciences' overall GF Score™ is 4/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Vitrafy Life Sciences (ASX:VFY), the current Total Stockholders Equity is A$41.11 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitrafy Life Sciences Business Description

Address 385 Bourke Street, Suite 2, Level 11, Melbourne, VIC, AUS, 3000
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy's Smart Cryopreservation Device; Vitrafy's Smart Thawing Device and Vitrafy's Smart Packaging.
4GF Score

Get the complete analysis for ASX:VFY

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$3.87
Price